AbbVie Invests $380M to Expand Illinois Manufacturing for Neuroscience, Obesity MedsFebruary 24, 20262 Mins Read2 Views AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its…
Effective but Underprescribed: HIV Prevention Meds Aren’t Reaching Enough PeopleFebruary 6, 20261 Min Read2 Views Listen: More than 2 million Americans could benefit from PrEP, but only about a quarter of them are getting the…
